Home  »  News   »  Here is why Tonix Pharmaceuticals Holding Corp. (T...

Here is why Tonix Pharmaceuticals Holding Corp. (TNXP) recent weekly performance of -8.46% shouldn’t bother you at All

For the readers interested in the stock health of Tonix Pharmaceuticals Holding Corp. (TNXP). It is currently valued at $1.12. When the transactions were called off in the previous session, Stock hit the highs of $1.29, after setting-off with the price of $1.19. Company’s stock value dipped to $1.16 during the trading on the day. When the trading was stopped its value was $1.19.Recently in News on January 24, 2023, Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations. Chatham, NJ –News Direct– Tonix Pharmaceuticals Holding Corp. You can read further details here

Tonix Pharmaceuticals Holding Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.5700 on 01/13/23, with the lowest value was $0.3920 for the same time period, recorded on 01/03/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Tonix Pharmaceuticals Holding Corp. (TNXP) full year performance was -85.25%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Tonix Pharmaceuticals Holding Corp. shares are logging -90.28% during the 52-week period from high price, and 287.54% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.29 and $11.52.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1434789 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Tonix Pharmaceuticals Holding Corp. (TNXP) recorded performance in the market was 205.28%, having the revenues showcasing 135.64% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 65.69M, as it employees total of 73 workers.

The Analysts eye on Tonix Pharmaceuticals Holding Corp. (TNXP)

During the last month, 0 analysts gave the Tonix Pharmaceuticals Holding Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.5868, with a change in the price was noted +0.12. In a similar fashion, Tonix Pharmaceuticals Holding Corp. posted a movement of +11.68% for the period of last 100 days, recording 4,963,410 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TNXP is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Tonix Pharmaceuticals Holding Corp. (TNXP)

Raw Stochastic average of Tonix Pharmaceuticals Holding Corp. in the period of last 50 days is set at 66.36%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 65.66%. In the last 20 days, the company’s Stochastic %K was 69.47% and its Stochastic %D was recorded 69.08%.

Considering, the past performance of Tonix Pharmaceuticals Holding Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 205.28%. Additionally, trading for the stock in the period of the last six months notably deteriorated by 0.00%, alongside a downfall of -85.25% for the period of the last 12 months. The shares increased approximately by -8.46% in the 7-day charts and went down by 283.87% in the period of the last 30 days. Common stock shares were driven by 135.64% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts